|
Plasma insulin and glucose levels as well as FMD during the oGTT (comparisons by paired Student's test, data represent mean ± standard deviation, #median) |
|||
| repaglinide |
control |
p |
|
|
|
|||
| Fasting Insulin (mU/l) |
7.16 ± 4.79 |
13.06 ± 20.97 |
n.s. |
| 1 hour Insulin (mU/l) |
72.40 ± 62.35 |
58.32 ± 48.39 |
n.s.* |
| 2 hour Insulin (mU/l) |
120.71 ± 86.78 |
49.83 ± 36.09 |
0.013* |
| Fasting glucose (mg/dl) |
106.58 ± 12.38 |
109.1 ± 16.3 |
n.s. |
| 1 hour glucose (mg/dl) |
222.08 ± 30.05 |
213.7 ± 29.9 |
n.s.* |
| 2 hour glucose (mg/dl) |
138.33 ± 41.19 |
172.8 ± 48.4 |
<0.001*** |
| Fasting FMD (%) |
8.18 ± 2.93 |
7.98 ± 2.24 |
n.s. |
| 1 hour FMD (%) |
5.50 ± 3.11 |
5.58 ± 2.91 |
n.s.* |
| 2 hour FMD (%) |
7.24 ± 2.57 |
6.21 ± 2.69 |
n.s. (0.102)** |
| 1 hour change FMD (%)# |
-2.25 |
-1.95 |
n.s.* |
| 2 hour change FMD (%)# |
-1.05 |
-1.6 |
n.s.* |
| Fasting NMD (%) |
15.09 ± 3.76 |
15.58 ± 3.74 |
n.s. |
|
*p < 0.001 vs. fasting for both groups **p = 0.028 vs. fasting for control, n.s. for repaglinide ***p < 0.001 vs. fasting for control, p = 0.005 for repaglinide | |||
Schmoelzer and Wascher Cardiovascular Diabetology 2006 5:9 doi:10.1186/1475-2840-5-9 |
|||